ONCOVALENT THERAPEUTICS Trademark

Trademark Overview


On Monday, June 29, 2020, a trademark application was filed for ONCOVALENT THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ONCOVALENT THERAPEUTICS trademark a serial number of 90027168. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 13, 2023. This trademark is owned by SUMO Biosciences Inc.. The ONCOVALENT THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals and medicines for the prevention and treatment of cancer; pharmaceuticals and medicines for the identification and treatment of tumors; pharmaceuticals preparations in the form of capsules, tablets, and powders for the treatment of cancer; intravenous pharmaceuticals, namely, vials for intravenous administration sold filled with preparations for the treatment of cancer; biological preparations for the prevention and treatment of cancer; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in the for testing and treatment of cancer; medical diagnostic reagents; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations in the nature of drug delivery agents that facilitate administration of other pharmaceutical preparations into the human body for enhanced treatment of cancer

Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; testing, inspection, research, or development of pharmaceutical preparations for the prevention and treatment of cancer; research and development of pharmaceuticals and medicines for the identification and treatment of tumors; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the fields of pharmaceutical and biological preparations; development of new technology for others in the fields of pharmaceuticals, biotechnology, and medicine; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; consulting services in the fields of biotechnology, pharmaceutical research and d...
oncovalent therapeutics

General Information


Serial Number90027168
Word MarkONCOVALENT THERAPEUTICS
Filing DateMonday, June 29, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 17, 2021

Trademark Statements


Goods and ServicesPharmaceuticals and medicines for the prevention and treatment of cancer; pharmaceuticals and medicines for the identification and treatment of tumors; pharmaceuticals preparations in the form of capsules, tablets, and powders for the treatment of cancer; intravenous pharmaceuticals, namely, vials for intravenous administration sold filled with preparations for the treatment of cancer; biological preparations for the prevention and treatment of cancer; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in the for testing and treatment of cancer; medical diagnostic reagents; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations in the nature of drug delivery agents that facilitate administration of other pharmaceutical preparations into the human body for enhanced treatment of cancer
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; testing, inspection, research, or development of pharmaceutical preparations for the prevention and treatment of cancer; research and development of pharmaceuticals and medicines for the identification and treatment of tumors; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the fields of pharmaceutical and biological preparations; development of new technology for others in the fields of pharmaceuticals, biotechnology, and medicine; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, and diagnostics; biological research and analysis; chemical research; medical research, namely, conducting clinical trials for others

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 27, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 27, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameONCOVALENT THERAPEUTICS SERVICE COMPANY
Party Type23 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNEWBURY PARK, CA 91320

Party NameSUVALENT THERAPEUTICS, INC.
Party Type22 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNEWBURY PARK, CA 91320

Party NameONCOVALENT THERAPEUTICS INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNewbury Park, CA 91320

Party NameSUMO Biosciences Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 91320

Party NameSUMO Biosciences Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 91320

Trademark Events


Event DateEvent Description
Monday, November 13, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 13, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, April 26, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, April 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 12, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, April 12, 2023SOU EXTENSION 3 GRANTED
Monday, April 10, 2023SOU EXTENSION 3 FILED
Monday, April 10, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, March 22, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 17, 2022SOU EXTENSION 2 GRANTED
Thursday, October 6, 2022SOU EXTENSION 2 FILED
Monday, October 17, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 6, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, April 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 11, 2022SOU EXTENSION 1 GRANTED
Monday, April 11, 2022SOU EXTENSION 1 FILED
Monday, April 11, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, October 12, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 17, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 17, 2021PUBLISHED FOR OPPOSITION
Wednesday, July 28, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 13, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 8, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 8, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 8, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 8, 2020NON-FINAL ACTION E-MAILED
Thursday, October 8, 2020NON-FINAL ACTION WRITTEN
Tuesday, September 29, 2020ASSIGNED TO EXAMINER
Monday, July 27, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 2, 2020NEW APPLICATION ENTERED